Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alkermes PLC

27.84
+0.17000.61%
Post-market: 27.840.00000.00%16:27 EDT
Volume:1.21M
Turnover:33.46M
Market Cap:4.59B
PE:12.83
High:27.88
Open:27.53
Low:27.32
Close:27.67
Loading ...

Alkermes to Report First Quarter Financial Results on May 1, 2025

THOMSON REUTERS
·
18 Apr

BRIEF-Alkermes - CFO Iain M. Brown Passes Away - SEC Filing

Reuters
·
16 Apr

Alkermes Plc - CFO Iain M. Brown Passes Away - SEC Filing

THOMSON REUTERS
·
16 Apr

Alkermes Down over 8%, On Pace for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
·
10 Apr

RBC Trims Price Target on Alkermes to $39 From $40, Keeps Sector Perform Rating

MT Newswires Live
·
03 Apr

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

Zacks
·
02 Apr

Alkermes Announces Initiation Of Vibrance-3 Phase 2 Study Evaluating Alks 2680 For The Treatment Of Idiopathic Hypersomnia

Reuters
·
01 Apr

BRIEF-Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia

Reuters
·
01 Apr

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating Alks 2680 for the Treatment of Idiopathic Hypersomnia

THOMSON REUTERS
·
01 Apr

Deutsche Bank Adjusts Alkermes Public Price Target to $52 From $40, Maintains Buy Rating

MT Newswires Live
·
27 Mar

Alkermes Is Maintained at Buy by Deutsche Bank

Dow Jones
·
27 Mar

Alkermes Plc : Deutsche Bank Raises Target Price to $52 From $40

THOMSON REUTERS
·
27 Mar

New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder

PR Newswire
·
27 Mar

Alkermes Plc : JP Morgan Raises Target Price to $34 From $26

THOMSON REUTERS
·
24 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vicarious Surgical (RBOT), Alkermes (ALKS) and Zealand Pharma (OtherZLDPF)

TIPRANKS
·
18 Mar

Alkermes' (NASDAQ:ALKS) investors will be pleased with their splendid 140% return over the last five years

Simply Wall St.
·
14 Mar

Alkermes Facing Near-Term Headwinds Across Existing Franchises, Royalties, RBC Says

MT Newswires Live
·
13 Mar

Alkermes Initiated at Sector Perform by RBC Capital

Dow Jones
·
13 Mar

S&P 500 Futures Drop In Premarket Trading; Alkermes, Intel Lead

Dow Jones
·
13 Mar

RBC Initiates Alkermes at Sector Perform With $40 Price Target

MT Newswires Live
·
13 Mar